We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant
REVBW

13 hedge funds and large institutions have $10K invested in Revelation Biosciences Warrant in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more capital inflows, than outflows

Capital inflows: $996 | Capital outflows: $506

18% more funds holding

Funds holding: 11 → 13 (+2)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Virtu Financial
Virtu Financial
New York
+$525
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$440
3
UBS Group
UBS Group
Switzerland
+$31

Top Sellers

Rank Fund Capital Flow
1
Soltis Investment Advisors
Soltis Investment Advisors
Utah
-$260
2
Citadel Advisors
Citadel Advisors
Florida
-$142
3
Pine Valley Investments
Pine Valley Investments
New Jersey
-$89
4
Clear Street
Clear Street
New York
-$6
5
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$5

REVBW Hedge Fund Activity: Q2 2026 in Review

13 of the 8,365 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q2 2026, worth a combined $10K — up 50% from $6.66K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new REVBW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 6 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $525. The largest seller was Soltis Investment Advisors, cutting an estimated $260.

  • 13 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q2 2026, up from 11 in Q1 2026.
  • Funds reported $10K of Revelation Biosciences Warrant stock for Q2 2026, up 50% quarter-over-quarter.
  • 2 funds opened new Revelation Biosciences Warrant positions in Q2 2026 and 0 closed out, a net change of +2 holders.
  • The largest Revelation Biosciences Warrant buyer in Q2 2026 was Virtu Financial, an estimated $525 added.
  • The largest Revelation Biosciences Warrant seller in Q2 2026 was Soltis Investment Advisors, an estimated $260 sold.

Based on aggregated 13F filings for Q2 2026.